Ligand validation:6BLX

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BLX_EDO_A_205	67%	84%	0.103	0.911	0.54	0.24	-	-	1	0	100%	1
6BLX_EDO_B_202	57%	55%	0.101	0.875	0.78	0.94	-	-	1	0	100%	1
6BLX_EDO_A_204	41%	81%	0.144	0.857	0.6	0.23	-	-	0	0	100%	1
6BLX_EDO_B_201	24%	78%	0.17	0.799	0.39	0.51	-	-	1	0	100%	1
6BLR_EDO_B_201	51%	92%	0.17	0.925	0.49	0.04	-	-	2	0	100%	1
6BLQ_EDO_A_207	50%	88%	0.209	0.961	0.36	0.3	-	-	1	0	100%	1
7Z50_EDO_B_302	46%	82%	0.178	0.912	0.46	0.34	-	-	0	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.7
3DPJ_EDO_B_195	100%	82%	0.022	0.994	0.47	0.34	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.